Top Analyst Upgrades and Downgrades (ABT, BLK, SAM, BREW, DVA, RE, FCX, AWAY, LNCO, TAP, PNR, TKC)
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Thursday.
Abbott Laboratories (NYSE: ABT) started as Outperform at William Blair.
BlackRock Inc. (NYSE: BLK) started as Overweight at J.P. Morgan.
Boston Beer Co. (NYSE: SAM) started as Neutral at Citigroup.
Craft Brew Alliance Inc. (NASDAQ: BREW) started as Neutral at Citigroup.
DaVita HealthCare Partners Inc. (NYSE: DVA) started as Overweight at JPMorgan.
EverestRe (NYSE: RE) raised to Overweight at J.P. Morgan.
Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) raised to Buy at Deutsche Bank.
HomeAway Inc. (NASDAQ: AWAY) raised to Overweight at Barclays.
LinnCo (NASDAQ: LNCO) started as Outperform at Wells Fargo.
Molson Coors Brewing Co. (NYSE: TAP) started as Neutral at Citigroup.
Partner Re (NYSE: PNR) cut to Underweight at J.P. Morgan.
Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) raised to Buy at BofA/Merrill Lynch.
Here are some other outside (and internal) outlook pieces for the end of 2012 and 2013:
- Nine Big Biotech Winners for 2013
- Imagine this: Coal could be a top performer in 2013 after two really bad years.
- Fortune's Top 10 Stocks to Buy for 2013
- BofA's 10 Defensive and Yield Stock Picks for 2013
- S&P 500 Upside Targets for 2013, from everyone
JON C. OGG
Filed under: 24/7 Wall St. Wire, Analyst Calls Tagged: ABT, AWAY, BLK, BREW, DVA, FCX, LNCO, PNR, RE, SAM, TAP, TKC